Biofilms Treatment Market Emerging Trends and Forecast

The biofilms treatment market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 7.9%. The growth of this market is majorly driven by the rising prevalence of chronic, surgical, and traumatic wounds and the increasing incidence of burn injuries. However, the high cost and low adoption rate of advanced wound care products are expected to limit the growth of this market to a certain extent.

Request for FREE PDF Sample Report @

List of Companies Profiled in the Report

  • Smith & Nephew (UK)
  • MiMedx Group Inc. (US)
  • ConvaTec Group plc (UK)
  • Coloplast A/S (Denmark)
  • Mölnlycke Healthcare AB (Sweden)
  • Organogenesis Holdings Inc. (US)
  • Integra LifeSciences Holdings Corporation (US)
  • B. Braun Melsungen AG (Germany)
  • PAUL HARTMANN AG (Germany)
  • Medline Industries Inc. (US)
  • Acelity (US)
  • Misonix (US)
  • Zimmer Biomet Holdings Inc. (US)
  • Kerecis (Iceland)
  • Welcare Industries S.p.A (Italy)
  • Medaxis AG (Switzerland)
  • PulseCare Medical (US)
  • Arobella Medical, LLC (UK)
  • RLS Global AB (Sweden)
  • Mil Laboratories Pvt. Ltd. (India)

“Gauzes and dressings segment accounted for the largest share of the biofilms treatment market in 2019”

Based on product, the biofilms treatment market is segmented into debridement equipment; gauzes and dressings; gels, ointments, and sprays; wipes, pads, and lavage solutions; and grafts and matrices. The gauzes and dressings segment accounted for the largest market share in 2019. This can be attributed to the ability of antimicrobial products to remove, prevent, and manage biofilms.

“Traumatic and surgical wounds segment will continue to dominate the biofilms treatment market during the forecast period”

Based on wound type, the biofilms treatment market is segmented into surgical and traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and burns and other open wounds. The surgical and traumatic wounds segment accounted for the largest market share in 2019. The large share of this segment can be attributed to the growing prevalence of diabetes and the increasing number of surgical procedures performed.

“North America dominates the global biofilms treatment market”

In 2019, North America accounted for the largest share of the biofilms treatment market, and this trend is expected to continue during the forecast period. The large share of this market can be attributed to the increasing incidence of chronic wounds, rising healthcare expenditure, the introduction of novel and specialty biofilm management products, and the presence of major market players in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 – 36%, Tier 2 – 45%,and Tier 3 -19%
  • By Designation: C-level – 33%, D-level – 40%, and Others – 27%
  • By Region: North America – 39%, Europe – 30%, Asia Pacific – 20%, Latin America- 8%, and the Middle East and Africa- 3%

Research Coverage:

This report provides a detailed picture of the global biofilms treatment market. It aims at estimating the size and future growth potential of the market across different segments, such as product, end user, wound type,and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall biofilms treatment market and its sub segments.It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, and opportunities.

Get Discount on the Latest Report @

Table of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Market Scope
1.2.2 Years Considered For The Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.2 Research Approach
2.2.1 Secondary Data Key Data From Secondary Sources
2.2.2 Primary Data
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown And Data Triangulation
2.5 Assumptions For The Study

3 Executive Summary

4 Premium Insights
4.1 Biofilms Treatment Market Overview
4.2 Biofilms Treatment Market, By Product, 2020 Vs. 2025 (Usd Million)
4.3 Biofilms Treatment Market Share, By End User, 2020 Vs. 2025
4.4 Biofilms Treatment Market: Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers Growing Prevalence Of Chronic, Surgical, And Traumatic Wounds High Incidence Of Obesity Growing Geriatric Population Increasing Prevalence Of Diabetes Increase In The Number Of Surgical Wounds And Ssis Increasing Number Of Traumatic Wounds Increasing Incidence Of Burn Injuries
5.2.2 Opportunities Growth Potential In Emerging Economies
5.2.3 Challenges High Cost And Low Adoption Rate Of Advanced Wound Care Products

6 Biofilms Treatment Market, By Product
6.1 Introduction
6.2 Debridement Equipment
6.2.1 Development Of Novel Technologies To Support Market Growth
6.3 Gauzes And Dressings
6.3.1 Gauzes And Dressings Are Designed To Prevent The Occurrence Of Infections After Debridement Procedures
6.4 Grafts And Matrices
6.4.1 Grafts And Matrices Promote Healing And Wound Closure
6.5 Wipes, Pads, And Lavage Solutions
6.5.1 Lavage Solutions Are Used For Cleaning Wounds During Hydro Surgical And Mechanical Debridement Procedures
6.6 Gels, Ointments, And Sprays
6.6.1 These Products Are Used To Treat Burns, Diabetic Foot Ulcers, And Surgical & Traumatic Wounds

7 Biofilms Treatment Market, By Wound Type
7.1 Introduction
7.2 Surgical And Traumatic Wounds
7.2.1 Growing Volume Of Surgical Procedures Performed To Support Market Growth
7.3 Diabetic Foot Ulcers
7.3.1 Rising Prevalence Of Diabetes Is A Key Factor Driving The Growth Of This Segment
7.4 Pressure Ulcers
7.4.1 Geriatric Population Is More Susceptible To Developing Pressure Ulcers
7.5 Venous Leg Ulcers
7.5.1 Increasing Prevalence Of Obesity To Support Market Growth
7.6 Burns & Other Open Wounds
7.6.1 Incidence Of Burn Injuries Is High In Emerging Countries

8 Biofilms Treatment Market, By End User
8.1 Introduction
8.2 Hospitals, Ascs, And Wound Care Centers
8.2.1 Rising Incidence Of Hospital-Acquired Pressure Ulcers And Infections To Support Market Growth
8.3 Home Care Settings
8.3.1 Rising Preference For Home Healthcare Is Contributing To The Growth Of This Market
8.4 Other End Users

9 Biofilms Treatment Market, By Region
9.1 Introduction
9.2 North America
9.2.1 Us Rising Prevalence Of Diabetes And Favorable Reimbursement Policies In The Country To Boost The Market Growth
9.2.2 Canada Increasing Government Support To Boost Market Growth
9.3 Europe
9.3.1 Uk Increase In R&D Activities To Propel Market Growth In The Uk
9.3.2 Germany Increasing Incidence Of Diabetes Will Boost The Market Growth In Germany
9.3.3 Russia Government Focus On Increasing Diabetes Awareness Will Favor Market Growth In Russia
9.3.4 France Rising Geriatric Population To Drive The Demand For Advanced Wound Care Products In The Country
9.3.5 Italy Unfavorable Reimbursement Scenario For Advanced Wound Care Will Hinder Market Growth In Italy
9.3.6 Spain Rising Geriatric Population In The Country To Support Market Growth
9.3.7 Rest Of Europe
9.4 Asia Pacific
9.4.1 China Increasing Incidence Of Dfus To Support Market Growth In China
9.4.2 Japan Favorable Regulations In Japan Have Boosted Product Launch And Commercialization Activity
9.4.3 India High Rate Of Ssis And Growing Investments Indicate Strong Opportunities For Market Growth
9.4.4 Australia Increasing Initiatives To Spread Awareness On Effective Wound Care To Support Market Growth
9.4.5 Rest Of Asia Pacific
9.5 Latin America
9.5.1 Brazil Brazil Is The Largest Market For Healthcare In The Latin American Region
9.5.2 Mexico Diabetes Is The Second-Highest Cause Of Mortality In Mexico
9.5.3 Rest Of Latin America
9.6 Middle East & Africa
9.6.1 Growing Prevalence Of Diabetes To Support Market Growth

10 Competitive Landscape
10.1 Introduction
10.2 Market Share Analysis, 2019
10.2.1 Biofilms Treatment Market, By Key Player
10.2.2 Biofilms Treatment Market For Hospitals
10.2.3 Biofilms Treatment Market For Home Care Settings
10.3 Competitive Leadership Mapping (Overall Market)
10.4 Vendor Inclusion Criteria
10.5 Vendor Dive
10.5.1 Visionary Leaders
10.5.2 Innovators
10.5.3 Dynamic Differentiators
10.5.4 Emerging Companies
10.6 Competitive Scenario
10.6.1 Product Launches & Approvals
10.6.2 Acquisitions
10.6.3 Collaborations & Partnerships

11 Company Profiles
(Business Overview, Products Offered, Recent Developments, Swot Analysis, Mnm View)*
11.1 Smith And Nephew Plc
11.2 Mimedx Group
11.3 Convatec Group Plc
11.4 Integra Lifesciences Holdings Corporation
11.5 Paul Hartmann Ag
11.6 Mölnlycke Health Care Ab
11.7 Coloplast A/S
11.8 B. Braun Melsungen Ag
11.9 Organogenesis Holdings Inc.
11.10 Misonix
11.11 Acelity (A Part Of 3m)
11.12 Zimmer Biomet Holdings Inc.
11.13 Kerecis
11.14 Medline Industries, Inc.
11.15 Welcare Industries S.P.A
11.16 Medaxis Ag
11.17 Pulsecare Medical
11.18 Arobella Medical, Llc
11.19 Advancis Medical
11.20 Rls Global Ab
11.21 Mil Laboratories Pvt. Ltd.

*Business Overview, Products Offered, Recent Developments, Swot Analysis, Mnm View Might Not Be Captured In Case Of Unlisted Companies.

Share This Post